The knock-down study of miR-101 on PC cell lines confirmed that the miRNA targets EZH2 and the loss of miR-101, which was effectively found in most of the IPMN samples, could stimulate the PDAC by upregulating EZH2. Here, EZH2 is linked to pachyonychia congenita.